The first Actos lawsuit has gone to trial in a California Superior Court in Los Angeles, known as Cooper v. Takeda Pharmaceuticals America Inc. Cooper v. Takeda is being heard…
Read More
On the heels of Johnson & Johnson's loss in a California Superior Court case regarding their DePuy ASR Hip implant, the second DePuy ASR Hip lawsuit started on March 11…
Read More
Testimony provided in late March by a urologist in an Actos trial taking place in a Los Angeles court presented an expert's opinion about the link between Actos and bladder…
Read More
In 2003, Takeda Pharmaceuticals Inc. expressed concerns about whether Actos users could develop cancer. These reservations on the part of the Japanese pharmaceutical company came to light in court documents…
Read More
DePuy President, Andrew Ekdahl, delivered testimony during day three of Strum v. DePuy, a case being heard in a Chicago state court. The DePuy ASR Hip lawsuit involves Carol Strum,…
Read More
Takeda Pharmaceuticals, the Japanese pharmaceutical giant responsible for the development and marketing of the diabetes drug Actos, concealed the association between Actos and bladder cancer, a jury was recently told…
Read More
Published March 19, 2013 by PR Web St. Louis, Missouri (PRWEB) March 19, 2013 With defective medical device lawyers currently investigating DePuy ASR Hip Replacement system cases, Carey Danis &…
Read More
A California jury recently awarded a compensatory package of $6.5 million to a plaintiff in an Actos bladder cancer lawsuit. The case, Cooper v. Takeda, was heard over a two…
Read More
The first trial in more than 3,000 Actos lawsuits filed in the U.S. is currently being heard in a Los Angeles court. Lawyers at Carey Danis & Lowe reported last…
Read More
On March 8, the jury in Kransky v. DePuy awarded the plaintiff in the case a compensatory award of $8.3 million. The compensatory damages to be paid to the plaintiff,…
Read More